EarningsIBP

IBP Earnings Update

Published
Last verified by BullBD

Announcement summary

What happened
IBP published a corporate disclosure on 18 October 2018. Read the full announcement for details.
Company
Indo-Bangla Pharmaceuticals Limited
Announcement published

Original announcement

(Continuation news of IBP: Q3): the 9 (nine) months period ended on 31 March 2018 against profit after tax of Tk. 73.99 million and basic EPS of Tk. 1.01 for the same period of the previous year. However, Post-IPO EPS would be Tk. 0.80 for 9 (nine) months period ended on 31 March 2018. NAV per share (considering Pre-IPO paid up shares) would be Tk. 13.86 as on 31 March 2018 and the same would be Tk. 13.03 (considering Post-IPO paid up shares). (cont. 2)

Source & verification

Source
Published company disclosure
Published through
Dhaka Stock Exchange
Announcement ID
616aced55a6b00004005baf8
Original publication
Last verified by BullBD
Translation
BullBD
Report incorrect information

Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.